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Sir— The original version of our manuscript [1] included the refer­
ence to vincristine that Dr. Ena and colleagues refer to [2], but that 
reference was deleted during revision of the manuscript because of 
space constraints. Vincristine remains an unproven, albeit poten­
tially useful, therapy for thrombocytopenia. Prospective studies 
are needed to determine what role this agent will play in the 
treatment o f thrombocytopenia.
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Recurrent Erysipelas or Erysipelas-like Rash?
Sir— The photo quiz in the June 1995 issue of Clinical Infectious 
Diseases [1] reminded us of a case with a very similar presentation 
in which our differential diagnosis included familial Mediterranean 
fever (FMF) and familial Hibernian fever (FHF) [2,3]. Our patient, 
a Dutch male who was bom in 1948, had a history of episodes of 
fever, erysipelas-like rash over the buttocks, and edema of the 
genitals (figure 1) and signs of acute-phase response (raised eryth­
rocyte sedimentation rate and neutrophilia). The disease started at 
the age of 14 and occurred 3 -8  times per year [4]. The patient’s 
family history revealed that his father, who had died, may also 
have had recurrent erysipelas-like lesions.
Since the patient had not responded to treatment with penicil­
lin (for presumed erysipelas) or to prophylaxis with colchicine 
(for FMF), we considered the possibility o f FHF in our differen­
tial diagnosis; in this disease, skin lesions are associated with 
painful erythema of the arms, trunk, and legs [3]. In 1987, 
however, he experienced a severe attack. At this time the patient 
had exanthem and a high fever (temperature of Ss40°C) as well 
as painful shoulders and knees. He was treated with predniso­
lone and azathioprine for presumed FHF and/or vasculitis. His 
condition did not improve, and he was transferred to the Aca­
demic Medical Center in Amsterdam with a diagnosis of poly­
myositis.
On admission to the hospital, he had exanthem and his right 
upper arm was swollen; in addition, he had severely restricted 
movements of his shoulder joints in all directions. The erythro­
cyte sedimentation rate was 110 mm/h, and the WBC count 
was 18.6 X 10l,/L. A roentgenogram of his shoulders showed 
severe joint destruction. An echogram revealed an abscess in 
his right upper arm; pus was obtained by puncture of the ab­
scess, and culture yielded group A /3-hemolytic streptococci. 
The patient responded to a 14-day course of iv penicillin ther­
apy (12 million units per day).
Reprints or correspondence: Dr. Jos W. M. van der Meer, Department of 
General Internal Medicine, University Hospital Nijmegen, P.O. Box 9101, 
6500 HB Nijmegen, the Netherlands.
Clinical Infectious Diseases 1996;22:881-2
1996 by The University of Chicago. All rights reserved.
1058-4838/96/2205 0056S02.00
Figure 1. Erysipelas-like skin 
male with recurrent erysipelas,
buttocks o f  a Dutch
The patient relapsed 1 month after his discharge from the hospi­
tal; he was again treated with iv penicillin, which was followed 
by oral penicillin. He did not have any attacks for 4 months, after 
which the antibiotic therapy was stopped. Me relapsed again and 
prophylaxis with penicillin was started, He did not have any attacks 
for at least 1 year, In retrospect, it is not unlikely that the treatment 
with prednisolone and azathioprine resulted in streptococcal hue 
teremia that caused septic arthritis and abscess formation; the last
us to believe that /?-hemolytie streptococci 
ill his attacks, and the diagnosis had to be changed to
With regard to Dr. Jones’ case, we believe that the diagnosis 
of erysipelas should be considered, especially since the clinical 
presentation was atypical for FMF and the patient did not respond 
to colchicine; according to published reports, colchicine prevents 
attacks in 64% of patients with FMF and markedly reduces the 
frequency and severity of attacks in 31% of these patients [5,
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Progressive Multifocal Leukoencephalopathy 
Defining Condition in a Patient with Human 
Immunodeficiency Virus Infection
Sir— We read with interest the recent article by Fong et al. [ 1 ] 
describing progressive multifocal leukoencephalopathy (PML) in 
patients with AIDS. They found that the mean (±SE) CD4+ cell 
count at the time of presentation or diagnosis was 85 ± 82/mm3 
and that only two of 28 patients had CD4+ cell counts of >200/ 
mm3. Also significant was the difference in survival time between 
patients with CD4+ cell counts of < 90/mm3 and those with CD4+ 
cell counts of >  90/mm3 at the time of presentation. We report an 
additional case in which PML was an AIDS-defining condition in 
a patient with HIV infection, who had a CD4+ cell count of 198/ 
mm3 at the time of diagnosis.
A 30-year-old, HIV-infected female was transferred to our ser­
vice for evaluation of progressive neurological complications, in­
cluding right-sided hemiparesis. One week before admission, she 
was hospitalized twice for fever, malaise, and decreased level of 
consciousness. Dysarthria had progressed to mutism 2 days before, 
and she was unable to clear copious oropharyngeal secretions.
The patient’s condition had been diagnosed as AIDS-related 
complex 5 years earlier, and she had begun treatment with zidovu­
dine that was followed by didanosine therapy and prophylaxis with
trimethoprim-sulfamethoxazole. Candida agitis had been
suspected, and no opportunistic infections had been previously 
identified. Her medical history included hepatitis B and C, pelvic 
inflammatory disease, anogenital condylomata, maxillary sinusitis, 
pneumonia, motor aphasia, intravenous drug abuse, prostitution, 
and multiple suicide attempts.
A physical examination revealed a cachectic woman who was 
responsive only to pain. Her temperature was 38.9°C, and her 
pupils were dilated bilaterally 3 -4  mm and were reactive. Mild 
nuchal rigidity and right hemiparesis were observed, as were a 
contracted right hand, a flaccid right lower extremity, and a positive 
right Babinski’s sign. Coarse rhonchi were present bilaterally.
The findings of laboratory studies indicated markedly elevated 
results of liver function tests as well as a moderate amount of blood 
and a high number of bacteria in the urine. A drug screen was 
negative. Findings on a chest roentgenograph were unremarkable. 
Cultures for fungi, viruses, and bacteria were negative. CT of the
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Figure 1. Head CT and MRI scans show multiple areas of demye- 
linization involving the brain stem and paraventricular white matter 
in a woman with AIDS who developed progressive multifocal leu­
koencephalopathy.
head (with contrast) demonstrated focal ischemic areas in the left 
parietal lobe. MRI revealed multiple areas of abnormal signal on T- 
2 weighting that involved the brain stem and paraventricular white 
matter (figure 1); it also showed severe maxillary sinusitis. An electro­
encephalogram (EEG) depicted generalized slow frequency, which 
was consistent with mild, diffuse encephalopathy. An EEG to measure 
auditory evoked response also revealed abnormalities.
Examination of CSF specimens did not reveal any abnormalities. 
Cultures for fungal, viral, and bacterial pathogens, including anaer­
obes and acid-fast bacilli, were negative. A VDRL (venereal disease 
research laboratory) test was nonreactive, and PCR for cytomegalovi­
rus (CMV) was negative. The CD44- cell count was 198/mm3 with 
a CD4/CD8 ratio of 0.5. Cultures for Mycobacterium avium complex, 
a test for serum cryptococcal antigen, and buffy coat stain and culture 
for CMV were negative. Serologies for human T-cell lymphotropic 
virus type 1 and 2 and for CMV were negative. Immunological tests
